| # | Drug | Count |
|---|---|---|
| 0 | EFAVIRENZ | 7 |
| 1 | ATAZANAVIR | 5 |
| 2 | RITONAVIR | 5 |
| 3 | RITONAVIR 100 MG | 5 |
| 4 | CALCIUM | 4 |
| 5 | INFLIXIMAB | 3 |
| 6 | LENALIDOMIDE | 3 |
| 7 | AMLODIPINE | 2 |
| 8 | ETANERCEPT | 2 |
| 9 | LEVOTHYROXINE SODIUM | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EFAVIRENZ | 7 | 0.0006 |
| 1 | TESTOSTERONE ENANTHATE | 1 | 0.0006 |
| 2 | ATAZANAVIR | 5 | 0.0003 |
| 3 | RITONAVIR 100 MG | 5 | 0.0003 |
| 4 | BECLOMETHASONE DIPROPIONATE | 1 | 0.0002 |
| 5 | TAMOXIFEN CITRATE | 1 | 0.0002 |
| 6 | IDELALISIB | 1 | 0.0001 |
| 7 | CLOBETASOL PROPIONATE OINTMENT USP, 0.05% | 1 | 0.0001 |
| 8 | CLOBETASOL PROPIONATE | 1 | 0.0001 |
| 9 | MELPHALAN HYDROCHLORIDE | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 7 | 0.0003 |
| 1 | Protease Inhibitor [EPC] | 5 | 0.0001 |
| 2 | Cytochrome P450 3A Inhibitor [EPC] | 5 | 0.0001 |
| 3 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 4 | Progesterone [EPC] | 1 | 0.0000 |
| 5 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 6 | Calcium [EPC] | 4 | 0.0000 |
| 7 | Estrogen Receptor Antagonist [EPC] | 1 | 0.0000 |
| 8 | Pyrimidine Synthesis Inhibitor [EPC] | 1 | 0.0000 |
| 9 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 1 | 0.0000 |